REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 22nd, 2011 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • New York
Protect Pharmaceutical Corporation, a Nevada corporation, with principal office at 116 Village Boulevard, Suite 200, Princeton, NJ 08540 (hereinafter referred to as the “Company”),
INVESTMENT AGREEMENTInvestment Agreement • June 22nd, 2011 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • New York
WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to ten million dollars ($10,000,000) to purchase the Company's Common Stock, par value $0.005 per share (the "Common Stock"); and
EMPLOYMENT AGREEMENTEmployment Agreement • July 21st, 2010 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • New Jersey
THIS EMPLOYMENT AGREEMENT (the “Agreement”) made this 28th day of May 2010 by and between Protect Pharmaceutical Corporation, a Nevada corporation with offices in West Caldwell, New Jersey (the “Company”) and Bill Abajian, an individual residing in New Jersey [“Employee”). Company and Employee collectively referred to herein as Parties.
THIS EMPLOYMENT AGREEMENT IS DATED FEBRUARY 12, 2010 BETWEENEmployment Agreement • June 8th, 2010 • PROTECT PHARMACEUTICAL Corp • New York
PRO-TECT INC ("PRTT"), a corporation incorporated pursuant to the laws of the State of Nevada, United States of America, (referred to as the "Corporation")
CLAIMS ASSIGNMENT AGREEMENTClaims Assignment Agreement • September 26th, 2014 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • Utah
THIS CLAIMS ASSIGNMENT AGREEMENT (the “Agreement”) is made and entered into as of the 19th day of September 2014, by and between Blue Cap Development Corp., a Nevada corporation with its principal place of business in Salt Lake City, Utah (hereinafter referred to as “Assignor”); and Protect Pharmaceutical Corporation, a Nevada corporation with its principal place of business in Salt Lake City, Utah (hereinafter referred to as “Protect”).
PATENT PURCHASE AGREEMENTPatent Purchase Agreement • February 4th, 2011 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • New Jersey
This Patent Purchase Agreement ("Patent Purchase Agreement"), made and entered into this 19th day of January, 2011 (the “Effective Date”), is by and between Protect Pharmaceutical Corporation, a corporation organized and existing under and by virtue of the laws of the State of Nevada, having an office and place of business at 116 Village Boulevard, Suite 200, Princeton, NJ 08540 ("Seller"); and Grünenthal GmbH, a company organized under the laws of Germany, having offices at Zieglerstraße 6, 52078 Aachen/Germany (“Buyer”). Seller and Buyer are also referred to individually as a “Party” and collectively as the “Parties."
BOARD OF DIRECTORS RETAINER AGREEMENTBoard of Directors • December 10th, 2018 • PROTECT PHARMACEUTICAL Corp • Pharmaceutical preparations • Nevada
THIS BOARD OF DIRECTORS RETAINER AGREEMENT (the “Agreement”) is made as of November 28nd, 2018, by and between Protect Pharmaceutical Corporation., a Nevada Corporation (the “Company”) and Wajed Salam (the “Director”) (collectively, the “Parties”).
PATENT ACQUISITION AGREEMENTPatent Acquisition Agreement • June 8th, 2010 • PROTECT PHARMACEUTICAL Corp • New York
This Patent Acquisition Agreement (the “Agreement”) is entered into and effective as of February 12, 2010 (the “Effective Date”), by and among Nectid Inc., a Delaware corporation having a principal place of business at 116, Village Boulevard, Princeton, NJ 08540 (the “Assignor”), and Pro-Tect, Inc., a Nevada corporation, mailing address c/o Leonard E. Neilson, Attorney at Law, 8160 South Highland Drive, Suite 104, Salt Lake City, Utah (the “Assignee or “Company”). The Assignee and Assignor are individually referred to as “Party” and collectively as “Parties”
